Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID‐19

COVID‐19 can present with a variety of clinical features, ranging from asymptomatic or mild respiratory symptoms to fulminant acute respiratory distress syndrome (ARDS) depending on the host's immune responses and the extent of the associated pathologies. This implies that several measures need...

Descripción completa

Detalles Bibliográficos
Autores principales: Cismaru, Cosmin Andrei, Cismaru, Gabriel Laurentiu, Nabavi, Seyed Fazel, Ghanei, Mostafa, Burz, Claudia Cristina, Nabavi, Seyed Mohammad, Berindan Neagoe, Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753383/
https://www.ncbi.nlm.nih.gov/pubmed/33211389
http://dx.doi.org/10.1111/jcmm.15927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753383/
https://www.ncbi.nlm.nih.gov/pubmed/33211389
http://dx.doi.org/10.1111/jcmm.15927

Ejemplares similares